• Nishiyama, Y., Planque, S.A., Hanson, C.V., Massey, R.J., and Paul, S. CD4 binding determinant mimicry for HIV vaccine design. Front. Immun. 3:383, 2012. [DOI: 10.3389/fimmu.2012.00383]. (Invited article)
  • Planque, S.A., Mitsuda, Y., Nishiyama, Y., Karle, S., Boivin, S., Salas, M., Morris, M.-K., Hara, M., Liao, G., Massey, R.J., Hanson, C.V., and Paul, S. Antibodies to a superantigenic glycoprotein 120 epitope as the basis for developing a HIV vaccine. J Immunol. 189(11):5367-5381, 2012. Pubmed
  • Sapparapu, G., Planque, S., Mitsuda, Y., McLean, G., Nishiyama, Y., and Paul, S. Constant domain-regulated antibody catalysis. J Biol Chem. 287(43):36096-36104, 2012. Pubmed
  • Paul, S., Planque, S.A., Nishiyama, Y., Hanson, C.V., and Massey, R.J. Nature and nurture of catalytic antibodies. Adv Exp Med Biol. 750:56-75, 2012. Pubmed
  • Paul, S., Planque, S., Nishiyama, Y., Escobar, M., Barnett, Z., and Massey, R.J. Covalent Vaccination and Catalytic Antibodies A new way of looking at and dealing with HIV. GMHC “Treatment Issues.” June 2011. GMHC Print version published in POZ magazine, June 2011:21-25.
  • Paul, S., Planque, S., Nishiyama, Y., Escobar, M.E., and Hanson, C.V. Back to the future: Covalent epitope-based HIV vaccine development. Expert Rev Vaccines. 9:1027-1043, 2010. Pubmed
  • Planque, S., Salas, M. Mitsuda, Y., Sienczyk, M., Escobar, M.E., Mooney, J.P., Morris, M.-K., Nishiyama, Y., Ghosh, D., Kumar, A., Gao, F., Hanson, C.V., and Paul, S. Neutralization of genetically diverse HIV-1 strains by IgA antibodies to the gp120 CD4 binding site from long-term survivors of HIV infection. AIDS. 24:875-884, 2010. Pubmed
  • Nishiyama, Y., Planque, S., Mitsuda, Y., Nitti, G., Taguchi, H., Jin, L., Symersky, J., Boivin, S., Sienczyk, M., Salas, M., Hanson, C.V., and Paul, S. Towards effective HIV vaccination:  Induction of binary epitope reactive antibodies with broad HIV neutralizing activity. J Biol Chem. 284:30627-30642, 2009. Pubmed
  • Paul, S., Planque, S.A., Nishiyama, Y., and Hanson, C.V.  A covalent HIV vaccine: Is there hope for the future? Future Virology (Editorial) 4:7-10, 2009. NIH public access
  • Planque, S., Salas, M., Escobar, M.E., Morris, M.-K., Jena, B., Mitsuda, Y., Sienczyk, M., Nishiyama, Y., Kumar, A., Gao, F., Montefiori, D.C., Hanson, C.V., and Paul, S. Survivors of HIV infection produce potent, broadly neutralizing IgAs directed to the superantigenic region of the gp120 CD4 binding site. XVII International AIDS Conference (AIDS 2008), 3-8 August, 2008, México City, México. Abstract Number THAA0305. Abstract  Slides
  • Planque, S., Sienczyk, M., Nishiyama, Y., Salas, M., Sapparapu, G., Mitsuda, Y., Taguchi, H., Boivin, S., Nitti, G., Montefiori, D., Hanson, C.V., and Paul, S. Prospective clinical utility and evolutionary implication of broadly neutralizing antibody fragments to HIV gp120 superantigenic epitope. XVII International AIDS Conference (AIDS 2008), 3-8 August, 2008, México City, México. Abstract Number LBPE1134.
  • Planque, S., Nishiyama, Y., Taguchi, H., Salas, M., Hanson, C., and Paul, S. Catalytic antibodies to HIV: Physiological role and potential clinical utility. Autoimmun Rev. (Invited Review) 7:473-479, 2008. Pubmed
  • Planque, S., Mitsuda, Y., Taguchi, H., Salas, M., Morris, M.-K., Nishiyama, Y., Kyle, R., Okhuysen, P., Escobar, M., Hunter, R., Sheppard, H.W., Hanson, C., and Paul, S. Characterization of gp120 hydrolysis by IgA antibodies from humans without HIV infection. AIDS Res Hum Retroviruses. 23:1541-1553, 2007. Pubmed
  • Nishiyama, Y., Karle, S., Planque, S., Taguchi, H., and Paul, S. Antibodies to the superantigenic site of HIV-1 gp120: Hydrolytic and binding activities of the light chain subunit. Mol Immunol. 44:2707-2718, 2007. Pubmed
  • Nishiyama, Y., Mitsuda, Y., Taguchi, H., Planque, S., Salas, M., Hanson, C.V., and Paul, S. Towards covalent vaccination: Improved polyclonal HIV neutralizing antibody response induced by an electrophilic gp120 V3 peptide analog. J Biol Chem. 282:31250-31256, 2007. Pubmed
  • Nishiyama, Y., Planque, S., Mitsuda, Y., Taguchi, H., Jin, L., Boivin, S., Salas, M., Hanson, C., and Paul, S. A binary neutralizing determinant of gp120 defined by nucleophilic monoclonal antibodies. 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2007). July 22-25, 2007; Sydney, Australia. Abstract# TUPEA042.
  • Nishiyama, Y., Karle, S., Mitsuda, Y., Taguchi, H., Planque, S., Salas, M., Hanson, C., and Paul, S. Towards irreversible HIV inactivation: stable gp120 binding by nucleophilic antibodies. J Mol Recognit. 19:423-431, 2006. Pubmed
  • Paul, S., Karle, S., Planque, S., Taguchi, H., Salas, M., Nishiyama, Y., Handy, B., Hunter, R., Edmundson, A., and Hanson, C.  Naturally occurring proteolytic antibodies: Selective IgM-catalyzed hydrolysis of HIV gp120. J Biol Chem. 279:39611-39619, 2004. Pubmed
  • Karle, S., Planque, S., Nishiyama, Y., Taguchi, H., Zhou, Y.-X., Salas, M., Lake, D., Thiagarajan, P., Arnett, F., Hanson, C.V., and Paul, S. Cross-clade HIV-1 neutralization by an antibody fragment from a lupus phage display library. AIDS. 18:329–331, 2004. Pubmed
  • Paul, S., Planque, S., Zhou, Y.-X., Taguchi, H., Bhatia, G., Karle, S., Hanson, C., and Nishiyama, Y. Specific HIV gp120 cleaving antibodies induced by covalently reactive analog of gp120. J Biol Chem. 278:20429-20435, 2003. Pubmed